Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges

Cited by papers we hold 10

• Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines · 2025
  No notice
• Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application · 2020
  No notice
• Internalization mechanisms of cell-penetrating peptides · 2020
  No notice
• Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines · 2019
  No notice
• Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose · 2019
  No notice
• Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents · 2018
  No notice
• Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics · 2018
  No notice
• Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery · 2017
  No notice
• Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia · 2016
  No notice
• Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.